Citation Impact
Citing Papers
Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors
2010 Standout
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
2008 Standout
Predicting Survival in Pulmonary Arterial Hypertension
2010 Standout
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
2013 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Animal antimicrobial peptides: An overview
1998 Standout
Pulmonary hypertension in chronic obstructive pulmonary disease
2003
Gas diffusion and alveolar-capillary unit in chronic heart failure
2006
Ageing of the cardiovascular system during 33 years of aerobic exercise
1999
Cardiopulmonary Exercise Test Characteristics in Patients with Chronic Obstructive Pulmonary Disease and Associated Pulmonary Hypertension
2007
Treatment of Pulmonary Arterial Hypertension
2004 Standout
The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus
2013 StandoutNobel
Function of the drosophila pattern-recognition receptor PGRP-SD in the detection of Gram-positive bacteria
2004 StandoutNobel
Cardiac Function, Physical Exercise Capacity, and Quality of Life during Long-Term Thyrotropin-Suppressive Therapy with Levothyroxine: Effect of Individual Dose Tailoring
2000
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
The Arabidopsis Information Resource (TAIR): improved gene annotation and new tools
2011 Standout
Defensins: antimicrobial peptides of innate immunity
2003 Standout
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Patterns of Pathogenesis: Discrimination of Pathogenic and Nonpathogenic Microbes by the Innate Immune System
2009
Rate and Mechanism of Maximal Oxygen Consumption Decline with Aging
2003
Nanotechnology as a therapeutic tool to combat microbial resistance
2013 Standout
Exercise Standards for Testing and Training
2013 Standout
Inactivation of Conserved C. elegans Genes Engages Pathogen- and Xenobiotic-Associated Defenses
2012 StandoutNobel
Human β-defensins
2006
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Thyroid Hormone and the Cardiovascular System
2001 Standout
Human Peptidoglycan Recognition Protein-L Is an N-Acetylmuramoyl-L-alanine Amidase
2003
Neutrophil granules and secretory vesicles in inflammation
2003
Prognostic Power of Ventilatory Responses During Submaximal Exercise in Patients With Chronic Heart Disease
2002
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Role of the gut microbiota in immunity and inflammatory disease
2013 Standout
Biventricular Versus Conventional Right Ventricular Stimulation for Patients With Standard Pacing Indication and Left Ventricular Dysfunction
2006
Neutrophils and immunity: challenges and opportunities
2006 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
2005 Standout
Oxygen Uptake to Work Rate Relation Throughout Peak Exercise in Normal Subjects: Relevance for Rate Adaptive Pacemaker Programming
1999
Dynamics of Oxygen Uptake for Submaximal Exercise and Recovery in Patients With Chronic Heart Failure
1994
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study
2001 Standout
Hemodynamic basis of the reduced oxygen uptake relative to work rate during incremental exercise in patients with chronic heart failure
2002
Peak Oxygen Uptake and Cardiovascular Risk Factors in 4631 Healthy Women and Men
2011
Bosentan Therapy for Pulmonary Arterial Hypertension
2002 Standout
Detection and clinical relevance ofStaphylococcus aureusnasal carriage: an update
2013
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Analysis and Separation of Residues Important for the Chemoattractant and Antimicrobial Activities of β-Defensin 3
2008 StandoutNobel
Intestinal epithelial cells: regulators of barrier function and immune homeostasis
2014 Standout
The role of nasal carriage in Staphylococcus aureus infections
2005 Standout
Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis
2011
A cytoprotective perspective on longevity regulation
2013 StandoutNobel
Intrinsic Heart Rate Response as a Predictor of Rate-Adaptive Pacing Benefit
1995
Innate immunity of the newborn: basic mechanisms and clinical correlates
2007 Standout
Downregulation of the Drosophila Immune Response by Peptidoglycan-Recognition Proteins SC1 and SC2
2006 StandoutNobel
Immunomodulatory Properties of Defensins and Cathelicidins
2006
In human epidermis, β-defensin 2 is packaged in lamellar bodies
2003
Ventilatory mechanisms of exercise intolerance in chronic heart failure
1992
Evolution of the mammary gland from the innate immune system?
2006 StandoutNobel
Importance of abnormal lung perfusion in excessive exercise ventilation in chronic heart failure
1993
Antimicrobial peptides: therapeutic potential
2006
Disease induction by human microbial pathogens in plant-model systems: potential, problems and prospects
2006
The increase in pulmonary arterial pressure caused by hypoxia depends on iron status
2008 StandoutNobel
Exercise limitation in chronic heart failure: Central role of the periphery
1996
Structure and dynamics of the neutrophil defensins NP‐2, NP‐5, and HNP‐1: NMR studies of amide hydrogen exchange kinetics
1994
End-tidal CO2 pressure decreases during exercise in cardiac patients
2000
Staphylococcus aureusclumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization
2002
Exercise and Heart Transplantation
1991
Structural features and biological activities of the cathelicidin-derived antimicrobial peptides
2000
Control of adaptive immunity by the innate immune system
2015 Standout
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
2006 Standout
Inaccuracy of Noninvasive Estimates of VD/VT in Clinical Exercise Testing
1994
APD3: the antimicrobial peptide database as a tool for research and education
2015 Standout
Cardiopulmonary Exercise Testing in the Evaluation of Patients With Ventilatory vs Circulatory Causes of Reduced Exercise Tolerance
1994
Work‐rate affects cardiopulmonary exercise test results in heart failure
2004
Clinical Correlates and Prognostic Significance of Six-minute Walk Test in Patients with Primary Pulmonary Hypertension
2000
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Exercise Testing and Training in Children With Congenital Heart Disease
2010
Rapid and specific labeling of single live Mycobacterium tuberculosis with a dual-targeting fluorogenic probe
2018
Exercise and Physical Activity for Older Adults
2009 Standout
Conformational Preferences of Linear β-Defensins Are Revealed by Ion Mobility-Mass Spectrometry
2010 StandoutNobel
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults
2011 Standout
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association
2016 Standout
Peptide Fragments of a β-Defensin Derivative with Potent Bactericidal Activity
2010 StandoutNobel
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Recommendations on the use of exercise testing in clinical practice
2006
Cardiopulmonary evidence of exercise-induced silent ischaemia
2006
Human Antimicrobial Peptides and Proteins
2014
The role of exercise testing in impairment evaluation.
1987
Carbon dioxide pressure-concentration relationship in arterial and mixed venous blood during exercise
2001
Antimicrobial polypeptides
2003
Age‐predicted maximal heart rate in healthy subjects: The HUNT F itness S tudy
2012
Comparison of the microbicidal and muramidase activities of mouse lysozyme M and P
2004
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
The Effect of Cigarette Smoking on Exercise Capacity in Patients with Intermittent Claudication
1996
Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure.
1989
Role of YadA in resistance to killing of Yersinia enterocolitica by antimicrobial polypeptides of human granulocytes
1996
Cardiopulmonary Exercise Testing in the Clinical Evaluation of Patients With Heart and Lung Disease
2011
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Human Factor inStaphylococcus aureusNasal Carriage
2004
A Fluorogenic Trehalose Probe for Tracking Phagocytosed Mycobacterium tuberculosis
2020 StandoutNobel
Staphylococcus aureus Resists Human Defensins by Production of Staphylokinase, a Novel Bacterial Evasion Mechanism
2004
The Staphylococcus aureus surface protein SasG and its homologues promote bacterial adherence to human desquamated nasal epithelial cells
2003
Limited Effects of Endurance or Interval Training on Visceral Adipose Tissue and Systemic Inflammation in Sedentary Middle-Aged Men
2016
AN INTEGRATED APPROACH TO THE INTERPRETATION OF CARDIOPULMONARY EXERCISE TESTING
1994
The Dickinson W. Richards lecture. New concepts in assessing cardiovascular function.
1988
Works of Ami Oren being referenced
Contrasting Cardiovascular and Respiratory Responses to Exercise in Mitral Valve and Chronic Obstructive Pulmonary Diseases
1983
Defensins: microbicidal and cytotoxic peptides of mammalian host defense cells
1992
Killing of Fusobacterium nucleaturn, Porphyromonas gingivalis and Prevotella intermedia by protegrins
1998
Antimicrobial and Anti-Inflammatory Activity of Chitosan–Alginate Nanoparticles: A Targeted Therapy for Cutaneous Pathogens
2012
Granulysin-Derived Peptides Demonstrate Antimicrobial and Anti-Inflammatory Effects Against Propionibacterium acnes
2005
Determinants of Staphylococcus aureus Nasal Carriage
2001
Increased inflammation in lysozyme M–deficient mice in response to Micrococcus luteus and its peptidoglycan
2003
Relation of oxygen uptake to work rate in normal men and men with circulatory disorders
1987
Normal cardiopulmonary responses during incremental exercise in 20??? to 70-yr-old men
1994
Diffusing Capacity for Carbon Monoxide as a Predictor of Gas Exchange during Exercise
1987